Dexmedetomidine and Morphine as Adjuvants to US Guided Erector Spinae Plane Blocks in Elective Thoracic Surgeries

• Status: Not yet recruiting
• Trial end date: 2025-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study will be to compare the effects of morphine versus dexmedetomidine when used as adjuvants to local anesthetic (Ropivacaine) in Erector Spinae Plane Block under ultrasound guidance. A group without an adjuvant will also be compared to the groups.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dr Kassiani Theodoraki
• Collaborator: Sotiria General Hospital
• Treatments: Dexmedetomidine; Morphine; Ropivacaine

Criteria

Inclusion Criteria:

• patients undergoing elective thoracotomy for any cause (ASA I-III)

Exclusion Criteria:

• known allergy to local anesthetic

• local inflammation

• severe respiratory distress ( breathing dependence on accessory muscles)

• severe spinal deformities

• severe ipsilateral diaphragmatic paresis

• morbid obesity (BMI>35 kg/m2)

• blood coagulation disorder

• known contraindication for administration of dexmedetomidine or morphine

• severe cardiovascular disease

• systematic use of opioids due to chronic pain

• renal or hepatic failure

• patients who refuse to participate.